Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The evolution of CLL treatment

Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch,  Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015

How to decide the treatment of CLL in 2015

Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015

Developments in immunotherapy

Prof Lillian Siu - University Health Network, Toronto, Canada
Developments in immunotherapy ( Prof Lillian Siu - University Health Network, Toronto, Canada )
11 Mar 2015

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer

Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015

New approach to prostate cancer screening

Dr Sanoj Punnen - University of Miami, Miami, USA
New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )
27 Feb 2015

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015

mRCC: Are we doing all we can to manage adverse events?

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future?

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015

Optimizing Survival in Advanced Prostate Cancer: Conclusion

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Latest achievements in the p-medicine project

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Latest achievements in the p-medicine project ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Jan 2015

Global cancer and the importance of government engagement

Dr Chris Wild - Director of the International Agency for Research on Cancer
Global cancer and the importance of government engagement ( Dr Chris Wild - Director of the International Agency for Research on Cancer )
18 Dec 2014